Clinical Trial Update: Treat Autosomal Dominant Polycystic Kidney Disease With Oral Ketone Ester? [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring an oral ketone ester for autosomal dominant polycystic kidney disease (ADPKD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: ADPKD | Phase 2 | Status: UNKNOWN